IMUGENE LIMITED — Director's Dealing 2021

Dec 19, 2021

==> picture [116 x 41] intentionally omitted <==

ASX Announcement

Correction to Director’s Interest Notice

---

20 December 2021

Imugene Limited (ASX: IMU, Company) confirms the attached changes to Director’s interest of Mr Charles Walker.

The attached Appendix 3Y reflects Mr Walker’s total holdings in the Company.

As part of the Company’s internal review of Director’s holdings it has identified historic transactions in August 2021 relating to indirect holdings that had previously been omitted.

The Company confirms that it is aware of its listing rule obligations in relation to these disclosures and specifically listing rules 3.19A and 3.19B. The Company makes the following statements about the attached Appendix 3Y.

• 1) The Appendix 3Y is being filed to correct an administrative oversight and to record a recent sale of shares;

• 2) The Company has informed all Directors of the disclosure requirements set out in Listing Rules 3.19A, 3.19B and s205G of the Corporations Act. This requirement is also documented in the Company’s Security Trading Policy, available on the Company’s website; and

• 3) The Company is confident that the arrangements it currently has in place are adequate to ensure ongoing compliance with listing rule 3.19B.

Phillip Hains

Joint Company Secretary

IMUGENE LIMITED ACN 009 179 551 WWW.IMUGENE.COM info@imugene.com

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001. Amended 01/01/11

	Imugene Limited (ASX: IMU)
Name of Entity:
	009 179 551
ACN:

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director:	Charles Walker
Date of Last Notice:	25 May 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

director” should be disclosed in this part.
Direct or Indirect Interest		Direct and Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.		Director related entity.
Date of change		a) 20 August 2021 (SPP acquisition) b) 20 August 2021 (SPP acquisition) c) 15 December 2021(disposal)
No. of securities held prior to change				Options - 25,000,000 25,000,000
			Shares	Options
		Direct	9,948,456	-
		Indirect	3,490,210	25,000,000
		Total	13,438,666	25,000,000
Class		a) Fully paid ordinary shares b) Listed Options (ASX: IMUOD) c) Fully paid ordinary shares
Number acquired				Options - b) 6,669 6,669
			Shares	Options
		Direct	-	-
		Indirect	a) 13,338	b) 6,669
		**Total **	13,338	6,669

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed				Options - - -
			Shares	Options
		Direct	c) 7,652,639	-
		Indirect	c) 106,338	-
		**Total **	7,758,977	-
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		a) $0.30 b) SPP price c) $0.52	per share attaching options, $0.45 exercise to $0.5242 per share
No. of securities held after change				Options - 25,006,669 25,006,669
			Shares	Options
		Direct	2,295,817	-
		Indirect	3,397,210	25,006,669
		Total	5,693,027	25,006,669
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back		a) Share Purchase Plan. b) Share Purchase Plan. c) On-Market Trade.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 3 – Closed period

Were the interests in the securities or N/A contracts detailed above traded during a +closed period where prior written clearance was required? If so, was prior written clearance N/A provided to allow the trade to proceed during this period? If prior written clearance was N/A provided, on what date was this provided?

==> picture [39 x 23] intentionally omitted <==

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3